Cargando…

Androgen receptor variant 7 exacerbates hepatocarcinogenesis in a c-MYC-driven mouse HCC model

Androgen receptor variant 7 (AR-V7), an AR isoform with a truncated ligand-binding domain, functions as a transcription factor in an androgen-independent manner. AR-V7 is expressed in a subpopulation of hepatocellular carcinoma (HCC), however, its role(s) in this cancer is undefined. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kido, Tatsuo, Lau, Yun-Fai Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902460/ https://www.ncbi.nlm.nih.gov/pubmed/36746917 http://dx.doi.org/10.1038/s41389-023-00449-3

Ejemplares similares

Potential dual functional roles of the Y‐linked RBMY in hepatocarcinogenesis
por: Kido, Tatsuo, et al.
Publicado: (2020)

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis
por: Jia, Jiaoyuan, et al.
Publicado: (2020)

Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways
por: Xin, B, et al.
Publicado: (2017)

Roles of the Y chromosome genes in human cancers
por: Kido, Tatsuo, et al.
Publicado: (2015)

The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression
por: Kido, Tatsuo, et al.
Publicado: (2019)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer
por: Kido, Tatsuo, et al.
Publicado: (2014)

Aberrant activation of the human sex-determining gene in early embryonic development results in postnatal growth retardation and lethality in mice
por: Kido, Tatsuo, et al.
Publicado: (2017)

Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis
por: Lau, Yun-Fai Chris, et al.
Publicado: (2019)

MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
por: Tsai, Yi-Wen, et al.
Publicado: (2021)

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

The Suppressive Role of SOX7 in Hepatocarcinogenesis
por: Wang, Chong, et al.
Publicado: (2014)

The X-Linked Tumor Suppressor TSPX Interacts and Promotes Degradation of the Hepatitis B Viral Protein HBx via the Proteasome Pathway
por: Kido, Tatsuo, et al.
Publicado: (2011)

Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer
por: Kido, Tatsuo, et al.
Publicado: (2010)

Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
por: Cigliano, Antonio, et al.
Publicado: (2017)

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

The scaffold protein menin is essential for activating the MYC locus and MYC‐mediated androgen receptor transcription in androgen receptor‐dependent prostate cancer cells
por: Luo, Yakun, et al.
Publicado: (2021)

Mouse medulloblastoma driven by CRISPR activation of cellular Myc
por: Vo, BaoHan T., et al.
Publicado: (2018)

Molecular characterization of hepatocarcinogenesis using mouse models
por: Teoh, Wei Wei, et al.
Publicado: (2015)

Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis
por: Correia de Sousa, Marta, et al.
Publicado: (2021)

A Positive Role of c-Myc in Regulating Androgen Receptor and its Splice Variants in Prostate Cancer
por: Bai, Shanshan, et al.
Publicado: (2019)

The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner
por: Kido, Tatsuo, et al.
Publicado: (2019)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer
por: Guo, Haiyang, et al.
Publicado: (2021)

Androgen Receptor Variant–Driven Prostate Cancer II: Advances in Laboratory Investigations
por: Lu, Changxue, et al.
Publicado: (2020)

Correction: Molecular characterization of hepatocarcinogenesis using mouse models
por: Teoh, Wei Wei, et al.
Publicado: (2023)

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
por: Wang, Dong, et al.
Publicado: (2021)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
por: Chandrasekaran, Balaji, et al.
Publicado: (2023)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells
por: Ren, Hui, et al.
Publicado: (2017)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

TIA1 Loss Exacerbates Fatty Liver Disease but Exerts a Dual Role in Hepatocarcinogenesis
por: Dolicka, Dobrochna, et al.
Publicado: (2022)

PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2021)

Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains
por: Maronpot, Robert R.
Publicado: (2009)

Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2(nd) generation androgen receptor signaling inhibitors
por: Zhu, Yezi, et al.
Publicado: (2020)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Androgen Receptor Splicing Variant-7 in Breast Cancer: Clinical and Pathologic Correlations
por: Ferguson, Donna C., et al.
Publicado: (2022)

Androgen receptor variant-7 regulation by tenascin-c induced src activation
por: Thomas, Rintu, et al.
Publicado: (2022)

AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells
por: Lin, Cho-Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tltacgtambpg9fd3uppcj8hf9